Loading…
Absci Corporation is projected to rise to $12.16 by 2027, a +56% move from its current price of $7.78. ABSI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $7.39 | $7.79 | $8.21 | +0.13% |
| Aug 3 | $7.24 | $7.80 | $8.40 | +0.25% |
| Aug 4 | $7.13 | $7.81 | $8.55 | +0.38% |
| Aug 5 | $7.04 | $7.82 | $8.68 | +0.51% |
| Aug 6 | $6.97 | $7.83 | $8.80 | +0.63% |
| Aug 7 | $6.90 | $7.84 | $8.91 | +0.76% |
| Aug 8 | $6.84 | $7.85 | $9.01 | +0.89% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.84 | $7.85 | $9.01 | +0.89% |
| Week 2 | $6.51 | $7.92 | $9.63 | +1.78% |
| Week 3 | $6.29 | $7.99 | $10.15 | +2.68% |
| Week 4 | $6.12 | $8.06 | $10.62 | +3.59% |
| Week 5 | $5.97 | $8.13 | $11.07 | +4.51% |
| Week 6 | $5.85 | $8.20 | $11.50 | +5.44% |
| Week 7 | $5.74 | $8.28 | $11.92 | +6.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Absci Corporation is a clinical-stage biopharmaceutical company that develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc.
for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Absci is currently trading at $7.64 with a market cap of $1.29B and a rank of 2203. This places it among smaller-cap healthcare names with a focus on antibody therapeutics.
A major floor 64.5% below — a decisive break under it would weaken the trend.
The nearest floor, 11.3% below — buyers have tended to step in here.
The nearest ceiling, 49.4% above — a clean break opens room to run.
A major ceiling 73.4% above — clearing it would confirm fresh momentum.
Key ABSI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ABSI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.40 | Buy | $7.58 | Buy |
| MA 10 | $7.74 | Buy | $7.88 | Sell |
| MA 20 | $9.01 | Sell | $8.36 | Sell |
| MA 50 | $8.11 | Sell | $7.92 | Sell |
| MA 100 | $5.97 | Buy | $6.66 | Buy |
| MA 200 | $4.64 | Buy | $5.35 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.62 | Neutral |
| Stoch RSI (14) | 42.42 | Neutral |
| CCI (20) | -57.61 | Neutral |
| Williams %R (14) | -73.57 | Info |
| MACD (12,26,9) | -0.28 | Sell |
| ROC (12) | -20.29 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 26.43 | Neutral |
| TRIX (15) | -0.15 | Sell |
| Awesome (5,34) | -1.67 | Sell |
| Ultimate (7,14,28) | 36.32 | Neutral |
| Momentum (10) | -0.51 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 7.22 | Buy |
| ADX (14) | 24.50 | Sell |
| ATR (14) | 0.38 | Info |
The near-term technical picture shows bullish sentiment overall. The RSI(14) sits at 40, with the 50-day simple moving average at $8.05 and the 200-day simple moving average at $4.62.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.30 | $7.78 | $11.36 | 0% | Neutral | |
| $8.89 | $12.16 | $17.95 | +56% | Bullish | |
| $9.91 | $14.38 | $22.62 | +85% | Bullish | |
| $10.85 | $16.57 | $27.36 | +113% | Bullish | |
| $10.36 | $16.57 | $28.47 | +113% | Bullish | |
| $10.75 | $17.93 | $31.90 | +130% | Bullish | |
| $13.97 | $24.29 | $44.53 | +212% | Bullish | |
| $17.99 | $32.53 | $61.28 | +318% | Bullish | |
| $20.71 | $38.89 | $75.11 | +400% | Bullish | |
| $19.34 | $37.68 | $74.46 | +384% | Bullish | |
| $35.20 | $78.22 | $169.69 | +905% | Bullish | |
| $53.11 | $118.03 | $271.46 | +14.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.30 | $7.78 | $9.79 | +0.00% |
| September 2026 | $6.63 | $8.06 | $10.23 | +3.65% |
| October 2026 | $7.08 | $8.73 | $11.29 | +8.23% |
| November 2026 | $7.18 | $8.94 | $11.74 | +2.44% |
| December 2026 | $6.78 | $8.53 | $11.36 | -4.58% |
Click any year to see its month-by-month ABSI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ABSI is projected to trade between $2.30 and $11.36, averaging $7.78 — a potential gain of 0% from today's $7.78. Price action looks broadly range-bound.
Absci Corporation's 2027 outlook centres on $12.16, within a $8.89 to $17.95 range. That is up +56% on the projected 2026 average. That marks a +56% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ABSI could reach as high as $22.62, with a base case around $14.38 and support toward $9.91 — roughly +85% from $7.78. Momentum favours further upside here.
Expect ABSI to range from $10.85 to $27.36 through 2029. The $16.57 average target implies a +113% move from current prices. That is up +15% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ABSI price prediction for 2030 points to an average of $16.57 (low $10.36, high $28.47) — a potential gain of +113% on today's $7.78. Momentum favours further upside here.
In 2031, ABSI is projected to trade between $10.75 and $31.90, averaging $17.93 — a potential gain of +130% from today's $7.78. That is up +8% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Absci Corporation's 2032 outlook centres on $24.29, within a $13.97 to $44.53 range. That is up +35% on the projected 2031 average. That marks a +212% change versus current levels. Momentum favours further upside here.
By 2033, ABSI could reach as high as $61.28, with a base case around $32.53 and support toward $17.99 — roughly +318% from $7.78. Buyers look set to stay in control over this stretch.
Expect ABSI to range from $20.71 to $75.11 through 2034. The $38.89 average target implies a +400% move from current prices. That is up +20% on the projected 2033 average. Momentum favours further upside here.
The ABSI price prediction for 2035 points to an average of $37.68 (low $19.34, high $74.46) — a potential gain of +384% on today's $7.78. Buyers look set to stay in control over this stretch.
In 2040, ABSI is projected to trade between $35.20 and $169.69, averaging $78.22 — a potential gain of +905% from today's $7.78. That is up +108% on the projected 2035 average. Momentum favours further upside here.
Absci Corporation's 2050 outlook centres on $118.03, within a $53.11 to $271.46 range. That is up +51% on the projected 2040 average. That marks a +14.2x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ABSI today (≈ 128.534704 ABSI) could be worth
$15,170.33
+$14,170.33 (+1417%) by 2050 · US Dollar
Based on the average projected ABSI price of $118.03 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ABSIwould be worth at today's price.
$1,000 invested in ABSI on Jul 31, 2025 (≈ 353.3569 ABSI) would be worth
$2,749.12
+$1,749.12 (+174.9%) today · 2.75× · US Dollar
Based on a ABSI entry price of $2.83 vs. today's $7.78.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.56 | $1,029.1 | +2.9% |
| 1 month ago | $11.11 | $700.27 | -30.0% |
| 3 months ago | $4.92 | $1,581.3 | +58.1% |
| 6 months ago | $3.02 | $2,576.16 | +157.6% |
| 1 year ago | $2.83 | $2,749.12 | +174.9% |
| All time (5.0y) ago | $29.29 | $265.62 | -73.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ABSI forecast.
Our base-case forecast reaches $16.00 around 2029.
Implied market cap at $16.00: $2.71B
The multi-year forecast points to a rising price trajectory. In 2027 the avg is $12.08 with a 58.1-like implied upside, and by 2030 the avg is $16.44 with a 115.2-like implied upside. The forecast continues higher, with 2040 avg $78.42 and 926.5-like upside, and 2050 avg $116.76 with a 1428.2-like upside, indicating substantial longer-term upside potential despite near-term volatility.
The forecast also shows a bullish sentiment across these horizons. Near-term volatility is reflected in an annualized volatility of 100%.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $16.44, with a minimum of $10.19 and a maximum of $28.48, and an implied ROI of 115.2. The sentiment is bullish.
The forecast turns bullish from 2027 onward, with rising averages and ROIs (e.g., 2027 avg $12.08 and 2027 ROI 58.1; 2030 avg $16.44 and ROI 115.2), though 2026 is neutral and long-term horizons show substantial upside and risk.
Yes. The 2029 max is $27.37 and the 2028 max is $22.63, indicating the possibility to exceed $20 in those years.
Current price is $7.64 and market cap is $1.29B.
The near-term technical picture is bullish, with RSI(14) at 40, SMA50 at $8.05, SMA200 at $4.62, support at $6.90, resistance at $11.62, and a 30-day range of $5.36-$10.88.
Absci Corporation Community Discussion
0Share your Absci Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.